Health

Drugs, in the first nine months of 2021 the expenses for direct purchases exceed by 1.418 billion

ADVERTISING
Rome, 31 January – Aifa has made available the documents on the monthly monitoring of national and regional pharmaceutical expenditure for January / September 2021carried out on the basis of the agreed expenditure data and the summary accounting statements (Dcr) obtained from the Regions, as well as the data obtained from the new National Information System (NIS) of the Ministry of Health, on the traceability of the drug (Ministerial Decree of 15 July 2004).

ADVERTISING

ADVERTISING
1 of 6